Immunization programme against hepatitis B virus infection in Italy: cost-effectiveness

By Da Villa G.   Sepe A.  

Vaccine, Vol. 17, Iss. 13, 1999-01 ,pp. : 1734-1738

Elsevier

Access to resources Recommend Favorite

Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant

By Isaka M.   Yasuda Y.   Mizokami M.   Kozuka S.   Taniguchi T.   Matano K.   Maeyama J.-i.   Mizuno K.   Morokuma K.   Ohkuma K.   Goto N.   Tochikubo K.  

Vaccine, Vol. 19, Iss. 11, 2001-12 ,pp. : 1460-1466

Elsevier

Access to resources Recommend Favorite

Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children

By Liao S.-s.   Li R.-c.   Li H.   Yang J.-y.   Zeng X.-j.   Gong J.   Wang S.-s.   Li Y.-p.   Zhang K.-l.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2661-2666

Elsevier

Access to resources Recommend Favorite

Ten-year neonatal hepatitis B vaccination program, the Netherlands, 1982-1992: protective efficacy and long-term immunogenicity

By del Canho R.   Grosheide P.M.   Mazel J.A.   Heijtink R.A.   Hop W.C.J.   Gerards L.J.   de Gast G.C.   Fetter W.P.F.   Zwijneberg J.   Schalm S.W.  

Vaccine, Vol. 15, Iss. 15, 1997-10 ,pp. : 1624-1630

Elsevier

Access to resources Recommend Favorite

Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus

By Prince A.M.   Whalen R.   Brotman B.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 916-919

Elsevier

Access to resources Recommend Favorite